Free Trial

Verve Therapeutics (VERV) SEC Filings & 10K Form

Verve Therapeutics logo
$6.39 0.00 (0.00%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$6.32 -0.07 (-1.16%)
As of 06:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Verve Therapeutics SEC Filings

DateFilerForm TypeView
06/10/2025
3:17 PM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:15 PM
Verve Therapeutics (Filer)
Form EFFECT
05/14/2025
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
6:45 AM
Verve Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:48 AM
Verve Therapeutics (Filer)
Form ARS
04/25/2025
6:30 AM
Verve Therapeutics (Filer)
Form DEF 14A
04/17/2025
4:40 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
7:57 AM
Verve Therapeutics (Filer)
Form POS AM
02/27/2025
7:16 AM
Verve Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:45 AM
Verve Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:24 AM
Verve Therapeutics (Filer)
Form POSASR
02/27/2025
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
6:53 AM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G
01/10/2025
8:24 PM
ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
Form SCHEDULE 13G/A
01/10/2025
8:00 AM
Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Lister Troy (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Politi Jason (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
8:00 AM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM
Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
11/05/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:52 PM
VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
10/16/2024
12:06 PM
STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
09/09/2024
3:36 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G/A
08/08/2024
6:30 AM
Verve Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
6:30 AM
Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:47 AM
Verve Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
6:44 AM
Verve Therapeutics (Filer)
Form 8-K/A
06/28/2024
6:45 AM
MacLean Michael F (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
COATS LONNEL (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Cumbo Alexander (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
[No Brainer Gold Play]: “Show me a better investment.” (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
06/28/2024
6:45 AM
ADELMAN BURT A (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Mikhail Sheila (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:45 AM
Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:30 AM
Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2024
6:30 AM
Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2024
6:30 AM
Politi Jason (Reporting)
Verve Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
3:42 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
Form SC 13G
06/25/2024
4:05 PM
Lister Troy (Reporting)
Verve Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VERV) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners